Skip to main content

LGL GROUP INC

For the period ended Dec 31, 2024. Filed Mar 31, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 31, 2025

LGL$6.63+1.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Earnings Per Share

11.** Earnings per Common Share

The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated:

Year Ended December 31,
(in thousands, except for share data)20242023
Numerator for EPS:
Income from continuing operations$522$345
Less: Net income from continuing operations attributable to non-controlling interests9048
Income attributable to LGL Group common stockholders from continuing operations432297
(Loss) income from discontinued operations, net of tax—(28)
Net income attributable to LGL Group common stockholders$432$269
Denominator for EPS:
Weighted average common shares outstanding - basic5,352,9375,352,937
Dilutive effects (a):
Warrants192,310—
Restricted stock8,576—
Weighted average common shares outstanding - diluted5,553,8235,352,937
Income (loss) per common share attributable to LGL Group common stockholders:
Basic:
Income from continuing operations$0.08$0.06
(Loss) income from discontinued operations—(0.01)
Net income attributable to LGL Group common stockholders$0.08$0.05
Diluted:
Income from continuing operations$0.08$0.06
(Loss) income from discontinued operations—(0.01)
Net income attributable to LGL Group common stockholders$0.08$0.05
(a)For the year ended December 31, 2023, weighted average shares used for calculating earnings per share excludes warrants to purchase 1,051,664 shares of common stock as well as 20,117 shares from restricted stock awards as the inclusion of these instruments would be antidilutive to the earnings per share calculation. For more information on the warrants and restricted stock, refer to Note 10 - Stockholders' Equity and Note 9 - Stock-Based Compensation, respectively, to these Consolidated Financial Statements.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.